Sekar Kathiresan, MD, sits down with me to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics. Dr. Kathiresan discovered a way to predict risk of developing heart attacks even in patients who don’t possess risk factors. He founded this startup to discover
Opinions collide in this spirited debate about how physicians can and should enter conversations on political issues as I host my amazing guest Saurabh Jha who expounds on a recent Lancet article focused on the Kashmir conflict. Should physicians interfere with politics beyond how politics can affect care delivery. what about gun control? If you
Nathan Pennell, MD, PhD, Director of Thoracic Oncology at the Cleveland Clinic visits with me to deliberate on some timely topics in non-small cell lung cancer treatment just before the World Lung Conference convened. We discussed many topics such as screening, adjuvant therapy, metastatic disease treatments, and ensuring patient adherence to oral therapies. Amazing progress
Rebecca Berger, MD, a hospitalist in New York shares with me the dilemma of oncology patient handoffs as well as the physician-to-hospitalist relationship. I don’t vividly recall interacting with hospitalists when I started training in 1995, but the hospitalists movement has taken off after the year 2000 and I wanted to discuss with Dr. Berger
Jeremy Warner, MD, MS, sits down with me to discuss big data, explain how medical errors were part of the impetus toward EMR popularization, and project the future of EMRs and interoperability. So many daily complaints about EMR and I share many of these with my colleagues, but I charged Jeremy in finding us the
Matthew Katz, MD, a phenomenal radiation oncologist provides the distinguishing factors between all forms of radiation therapy used in oncology today, including brachytherapy, SBRT, hypofractionated radiation therapy, and proton therapy, among others. Understanding the different methods of delivering radiation therapy is important for patients and oncologists alike and the advances that have occurred in radiation
Narjust Duma, MD, thoracic oncologist at the University of Wisconsin, discussed with me gender bias in academic medicine, challenges facing women mentees, and her provocative research presentation at the recent 2019 ASCO annual meeting. What will it take to have gender equality especially in academic medicine? You’ll need to listen.
Jeremy Topin, MD, delves into a conversation with me that focuses on improving communication in end-of-life care and the societal shift necessary to change the negative stigma surrounding such care. I worked with Jeremy when we both were at Advocate Lutheran General Hospital. He is a critical care physician so he deals with end-of-life issues
the award-winning hematologist and a medical oncologist who hosted Outspoken Oncology, a podcast featuring candid discussions of the most pressing, and often controversial, medical topics. Combining his background in cancer research and health care advocacy, Dr. Nabhan brings a unique and powerful perspective to current medical events.
